Founded in 2010 with a vision to simplify this complexity, Concert Genetics (formerly NextGxDx, Inc.) launched as a healthcare technology company dedicated to streamlining the genetic test selection, ordering, payment and management for clinicians, hospitals, laboratories and health plans. With a leading team of clinicians, researchers, data scientists and software engineers, Concert Genetics launched its proprietary solutions to enable end-to-end genetic testing management, from searching and comparing testing products, to tracking orders and results, to payment integrity and forecasting trends in pricing and utilization.


Nashville, TN, USA

Concert Genetics

Sovereign's Capital primarily focuses on Healthcare, IT, and Consumer Products & Services - industries that will benefit from the rapidly expanding middle class and are under-represented in the public markets in Southeast Asia. Our fund aligns deep expertise among its principals and advisers in these focus areas.

Portfolio Company Careers